Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
Launched by SEATTLE CHILDREN'S HOSPITAL · Mar 11, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE) trial is studying how gut inflammation affects children with inflammatory bowel diseases, such as Crohn's Disease and Ulcerative Colitis. This research will also include a group of children who have issues with gut-brain interactions but do not have visible gut inflammation. The goal is to gather important long-term information and samples from these patients to better understand their conditions.
To be eligible for the study, participants should be children suspected of having Crohn's Disease, Ulcerative Colitis, or Indeterminate Colitis. However, they must not have other serious health problems, be pregnant, or have issues with substance abuse. Participants in this study can expect to provide clinical data and samples that will help researchers learn more about these diseases and potentially improve future treatments. If you or your child is interested, this could be a chance to contribute to important medical research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Suspected diagnosis of CD (Crohn's Disease), UC (Ulcerative Colitis) or Indeterminate colitis (IC)
- Exclusion Criteria:
- * Evidence of Other Complicating Medical Issues:
- • Other serious medical conditions, such as neurological, liver, kidney, or systemic disease
- • Pregnancy
- • Tobacco, alcohol, or illicit drug abuse
About Seattle Children's Hospital
Seattle Children's Hospital is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital focuses on developing new treatments and therapies that address the unique medical needs of children. With a commitment to excellence, Seattle Children's Hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to ensure rigorous scientific standards and ethical practices in all its clinical investigations. By prioritizing patient safety and scientific integrity, the hospital aims to contribute to the global body of knowledge in pediatric medicine and improve outcomes for children with various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Betty (Hengqi) Zheng, MD
Principal Investigator
Seattle Children's Hospital, University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported